It is currently Thu Feb 25, 2021 11:40 pm

Post new topic Reply to topic  [ 1 post ] 
 Mutated Swine Flu Strains Block Drugs, Worsen Illness (Updat 
Author Message
User avatar

Joined: Sun Oct 11, 2009 1:54 pm
Posts: 1128
Location: BC Canada
Post Mutated Swine Flu Strains Block Drugs, Worsen Illness (Updat
Mutated Swine Flu Strains Block Drugs, Worsen Illness (Update1)

Last Updated: November 20, 2009 16:26 EST
By Michelle Fay Cortez and Marianne Stigset ... 0royU2paW4

Nov. 20 (Bloomberg) -- Swine flu infections in which the virus mutated to a form that’s more severe or less sensitive to drug treatment are being investigated by European and U.S. public health officials.

Five patients at a hospital in Wales contracted swine flu that resisted treatment with Roche Holding AG’s Tamiflu, and three more infections are being analyzed, the U.K. Health Protection Agency said today. Four patients had resistance in a North Carolina hospital. A separate mutation that may trigger more severe illness was found in Norway among two patients who died of the flu and one who was severely ill.

While there is little risk posed by the mutations, investigators are monitoring the new clusters closely, according to health officials from the U.S. Centers for Disease Control and Prevention and the World Health Organization. Since swine flu was identified in April, there have been 57 cases of the influenza that resist Tamiflu treatment. There have been “sporadic” reports of mutations similar to those in Norway, the CDC’s Anne Schuchat said today in a briefing.

“We take this development seriously, but the HPA currently considers that the risk to the general healthy population is low,” the U.K. officials said in a statement about the Wales cases. “The Tamiflu-resistant virus has emerged in a group of particularly vulnerable individuals. These patients are known to be at increased risk of developing resistance to the drug.”

Mounting Cases

Swine flu, also known as H1N1, infected about 22 million people in the U.S. and killed 3,900 people from April to Oct. 17, according to the CDC’s most recent estimate. Norway has had an estimated 700,000 infections, with 21 reported deaths. The disease has killed at least 6,770 people worldwide, according to an estimate today from Geneva-based WHO. The agency no longer keeps an up-to-date count of global cases.

The Norway mutation is difficult to pass from person to person, said David Mercer, acting head of the communicable diseases unit of the WHO’s European region, and Geir Stene- Larsen, the head of the Oslo-based Institute of Public Health. The mutation was found in 3 of 70 patients tested, the institute said.

The infections in Wales may have passed from a person using Tamiflu to patients who haven’t taken the drug, raising the possibility that a hard-to-treat form of the disease may spread, according to the U.K. health agency. The U.S. cases occurred in October and November, according to the Atlanta-based CDC.

Weaker Immunity

The patients in Wales had blood diseases that weakened their immune systems, either because of the condition itself or the chemotherapy used to treat it, according to the U.K. agency. Resistance to Tamiflu is known to occur in patients with weak immune systems. All the Welsh patients remain sensitive to GlaxoSmithKline Plc’s Relenza, another antiviral treatment, the agency said.

In Norway, the changes seen in the virus may allow it to penetrate deeper into the airways and cause more severe disease.

“It seems that the mutated virus does not circulate in the population but might be a result of spontaneous changes which have occurred in these three patients,” Stene-Larsen said in a statement. “There is no indication that this change in the virus is of any importance for the effect of the vaccine or the effect of antiviral treatment.”

The virus in Norway appears to be sensitive to Tamiflu and the vaccine now being offered in some areas to prevent swine flu infection, said Mercer of the WHO.

“I don’t think it yet has the public health implications that we would wonder about,” said Schuchat, head of the CDC’s National Center for Immunization and Respiratory Diseases. Similar mutations have been seen elsewhere and haven’t necessarily led to a more virulent disease, she said.

“It’s most likely that the virus’ capability to mutate is not just specific to Norway, it will occur in other countries as well,” Stene-Larsen said in an interview on broadcaster TV2.

Something is going to happen, but what?

Fri Nov 20, 2009 5:07 pm
Profile WWW
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

Who is online

Users browsing this forum: No registered users and 1 guest

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Jump to:  
Powered by phpBB © 2000, 2002, 2005, 2007 phpBB Group.
Designed by Vjacheslav Trushkin for Free Forums/DivisionCore.